It is important to note that, beyond GC [43], recent studies also demonstrate the overexpression of IL-33 during the transition from GERD to EAC, and that IL-33 promotes carcinogenesis in EAC cells through ST2 [44]. The gene discussed is IL33; the disease is gastroesophageal reflux disease.